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Editorial
When it comes to finding a suitable in vivo experimental
model for the human gastrointestinal tract (GIT), it seems
that the pig is more equal than other animals. While non-
human primates might seem the obvious choice, they are too
difficult to work with in practice, partly because their very
human-ness generates public dismay at their experimental
use. The case in favour of the pig is here put by Guilloteau
et al. (1) who argue that it is particularly appropriate for
studies investigating nutritional programming of the GIT,
due to the similarities in structure, function and stage of
maturation during fetal and postnatal periods between
the two species. Furthermore, the nutritional needs of the
omnivorous pig are well characterised, and its nutrient
intake can be manipulated and controlled experimentally.
Of particular interest at the moment is the influence of body
weight at birth on the risk of chronic disease in adulthood;
thus it is particularly useful that sows conveniently produce
‘runts’ that have been growth-retarded in utero (i.e. are
small-for-gestational-age) as well as appropriate-for- and
large-for-gestational-age (LGA) piglets, often in the same
litter (thereby reducing genetic effects). In addition,
evidence is presented supporting the ‘sow–piglet’ dyad as
the most promising model for the ‘human mother–infant’
dyad in the study of the effects of intra-uterine growth
retardation, while further work is needed in the area of
LGA (hardly investigated), and on the long-term effects of
nutritional programming on the GIT, for which there are
surprisingly few data given its important role in nutrient
uptake. The reproductive and physiological characteristics
of pigs allow the study of short-, mid- and long-term effects
of nutritional programming on the offspring; in addition,
surgical procedures such as cannulation are relatively easy
and the use of pigs presents fewer economic and ethical
constraints than would be involved with non-human
primates. Ultimately, work with this versatile animal could
provide useful preventative and treatment strategies in
the areas of hypertension, CVD, obesity and diabetes for
we humans.
The relative lack of interest in the effects of infant feeding
on the functional development of the GIT is a point made
also by Le Huërou-Luron et al. (2) in a review highlighting
the results, including from their own work using the pig
model, showing that the infant diet modulates postnatal
developmental changes in intestinal and pancreatic func-
tion. Formula-feeding produces various alterations in gut
development (hypertrophy, increased intestinal permeability
and bacterial translocation) which might affect absorptive
capacity and gut-associated immune function; basal blood
glucose concentration is increased and plasma ketones
decreased by formula-feeding, while postprandial effects
(including the insulin response) are, as yet, unclear. Infant
formulae can be modified, for example, by reducing the
protein content or adding prebiotics, in order to attempt to
ameliorate the gut response such that infant development
more closely resembles that of the breast-fed infant; it is
in this context that these authors argue strongly that the
long-term effects of different feeding strategies on the
development of the GIT and the nutritional and immuno-
logical consequences should be further studied, using
animal models to control some of the many confounding
factors. This work is necessary in order to help us
understand better the mechanisms involved in the health
benefits of breast-feeding in both the short term (lower
incidence of diarrhoea and necrotising enterocolitis) and in
later life (lower incidences of obesity, type 2 diabetes and
inflammatory bowel disease). The intestinal microbiota may
play a significant role here, a role further explored in the
review by Adams(3) examining the beneficial biological
responses generated by both living and dead cells in
probiotic products, a phenomenon he terms the probiotic
paradox. Probiotics are generally understood to be dietary
supplements containing viable micro-organisms which
interact in a beneficial manner with the indigenous gut
microflora and the immune system. Modification of the
gastrointestinal microflora by probiotic therapy could be
useful in the treatment of clinical conditions affecting the
GIT, such as inflammatory bowel disease and Crohn’s
disease, and has been effective against (infectious and
rotoviral) diarrhoea in children and antibiotic-associated
diarrhoea; probiotics also inhibit pathogenic bacteria
(Salmonella, Helicobacter pylori), secrete bacteriocins and
enzymes, and remove cholesterol in the GIT (by assimila-
tion and binding to the cell surface). Potential benefits
extend beyond the gut, and could include the control of
inflammatory disease, prevention of allergic diseases, and
prevention of cancer, and respiratory disease via the
stimulation of the immune system. The micro-organisms
in probiotics could achieve their effects directly in the gut
(for example by killing/inhibition of pathogens) or,
indirectly, by competition for binding sites on the wall of
the GIT (required by pathogenic bacteria in order to produce
symptoms of disease). More subtly, probiotics can interact
with the cells of the immune system, affecting, for example,
the balance of pro- and anti-inflammatory cytokines. In
practice, Adams argues, many probiotic preparations
contain varying (and usually unknown) amounts of live
and dead cells, and, furthermore, even the living cells may
not survive their journey through the stomach and small
intestine; thus some of the benefits attributed to these
preparations could be actually be due to dead probiotic
cells, or their metabolites. Dead (usually heat-killed)
probiotics and their components have been investigated,
and a variety of biological responses reported, including
an enhanced immune reaction against resistance to
vancomycin-resistant enterococci in chicks fed heat-killed
Enterococcus faecalis (which would have commercial
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importance), and enhanced in vitro pro-inflammatory
cytokine production by macrophages cultured with heat-
killed bifidobacteria. In contrast, anti-inflammatory effects
have been reported in mice suffering from experimental
arthritis treated with both a live and a heat-killed strain of
Lactobacillus. Clearly, although some actions of probiotics
depend on the cells being alive (effects on the intestinal
microflora, immunomodulation), others do not (anti-
inflammatory effects); and Adams suggests that the use of
preparations of dead probiotic cells can offer several
advantages – for example, they would present no risk to
patients suffering from immunodeficiency. Furthermore,
preparations of dead probiotic cells or specific extracts of
their effective molecular components (for example, DNA,
polysaccharides) would be easier to store, more standar-
dised in their formulation than live preparations, better
survive passage through the stomach, and could even
include pathogenic organisms, thus providing potentially
promising applications for both human and animal health.
Transport across the gut and placenta cell epithelial cell
membrane is the subject of the review by Martel et al. (4),
specifically the effect of polyphenols on this function. These
compounds are antioxidants, and have attracted much
interest due to their probable role in the prevention of
various diseases associated with oxidative stress (cancer,
cardiovascular, neurodegenerative and inflammatory
diseases), an interest perhaps not unrelated to their presence
in red wine, beer and tea. Polyphenols are also modulators
of certain enzymes and cell membrane transporters (of, for
example, certain nutrients, including glucose, bioactive
amines and drugs) and these authors suggest that
interference by polyphenols with the transport of some
compounds could affect their bioavailability, at either the
gut, or the placenta following absorption of dietary
polyphenols into the mother’s blood. In the case of thiamin,
a connection is suggested between fetal alcohol syndrome
and deficiency of this vitamin, while, for folate, in vitro
studies indicate that different phenolic compounds have
different effects on placental transfer of folic acid in both the
short and long term. Similar work has suggested that the
polyphenols in wine and beer (as well as ethanol) decrease
the uptake of folic acid in the gut (unfortunately, tea and
orange juice are also culpable here), contributing to the
folate deficiency characteristic of this group. In contrast, a
potentially useful clinical application for polyphenols could
be in the regulation of glucose absorption in the gut in the
management of diabetes, and could perhaps even protect
against the development of the metabolic syndrome and/or
type 2 diabetes. Given the variety of types and effects
(including interferences and synergies between them) of
polyphenols present in foods, especially what are con-
sidered to be healthy foods, and in beverages, it is difficult to
draw firm conclusions from this review that could be
translated into health promotion messages, other than the
familiar mantra that one should consume a varied diet of
healthy foods, with nothing in excess.
Whole-grain cereals are another group of healthy
foods that have attracted interest, here investigated by
Fardet(5) who looks beyond fibre in his heroic review of
the mechanisms responsible for the health-promoting
effects, particularly of whole wheat. In addition to their
well-characterised antioxidant roles, the huge range of
bioactive compounds in cereals (mainly in the bran) have
recently been implicated in cell signalling and gene
regulation (polyphenols), cardiovascular and hepatic pro-
tection, lipid metabolism and DNA methylation (methion-
ine, betaine, choline, inositol and folates). Other roles and
associations, such as that of B vitamins with the nervous
system, oligosaccharides as prebiotics and the action of
phenolic acids in the colon, require further elucidation.
In addition, phytic acid and lignin, usually considered only
in the context of fibre, turn out to have significant
antioxidant properties. The complex and interconnected
effects of whole grains clearly need to be investigated
in vivo, and Fardet suggests that metabolomics would be a
useful adjunct to the existing measurements of biomarkers
used to date, for example, in the clarification of the effects
on the immune system and hence protection against cancer.
Further, he recommends that in vivo studies on gene-
regulatory actions of the bioactive compounds present in
whole grains should be performed, building on the mostly
in vitro work carried out to date. He also outlines means by
which the nutritional quality of cereal products could be
improved, for example, by simply using more intact
versions of cereal grain kernels in recipes, including flour
that is less refined (high extraction rate) or by modifying the
growing conditions, using fertiliser, or environmental
stressors such as cold, to increase the content of minerals
or antioxidants. More advanced strategies could include the
breeding of new varieties with improved nutrient compo-
sition, and the use of processes such as fermentation,
encapsulation, or extraction of the desired components (for
example, the aleurone layer) for reincorporation into foods.
This last would reduce potential risk from consuming
pesticides or mycotoxins present in the outer layers, though
it would obviously be better to produce cereals that are less
contaminated in the first place. At the same time the point is
made that we should continue to investigate the mechanisms
involved in order to work out how the best physiological
results can be achieved – a considerable challenge
considering the complexity of cause and effect he describes.
In addition to the physical effects of fibre in modulating
food intake, a new role for fibre in appetite regulation is
proposed by Sleeth et al. (6) in their review focusing on free
fatty acid receptor 2 (FFA2, formerly GPR43). This
receptor, present in the gut wall (and also other tissues
including the islet cells of the pancreas, bone-marrow,
spleen, and white and brown adipose tissue), binds SCFA
generated during fermentation in the colon, producing a
satiety effect, possibly via secretion of peptide YY which
then acts centrally to induce hypophagia; FFA2 may also
stimulate secretion of products of the pre-proglucagon gene,
including glucagon-like-peptide 1 (anorexigenic). In other
tissues, stimulation by SCFA of FFA2 has been shown to
reduce lipolysis and increase adipogenesis (adipose tissue),
and improve glucose control and dyslipidaemia; thus some
of the beneficial effects of fibre supplementation observed,
for example, in the control of the metabolic syndrome, could
be attributed to these mechanisms. These authors therefore
associate our reduction in fibre intakes, and hence loss of the
appetite-suppressive effect conferred via FFA2 by SCFA
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experienced worldwide. When more fully investigated, a
happy consequence of this link could be the development
of dietary or pharmacological strategies targeting FFA2
that could help against the development of obesity and
type 2 diabetes.
Current available pharmacological therapies for weight
reduction include the inhibition of pancreatic lipase, thereby
reducing the digestion and absorption of ingested lipid
(these preparations must therefore be used with caution,
due to the unpleasant and potentially embarrassing side-, or
should I say end-?, effects. . .). There is apparently little (and
inconsistent) literature concerning the physiological con-
ditions affecting the action of this enzyme, prompting the
review by Brownlee et al. (7), who are hopeful that
investigation of this area could lead to the development of
improved products that produce the wanted but not the
unwanted effects. One group which might avail of such
products is shift-workers, who, according to Antunes
et al. (8), are particularly prone to overweight and obesity
(also dyslipidaemia, the metabolic syndrome and CVD),
perhaps due to metabolic disturbances, for example, in lipid
or glucose metabolism (and the hormones governing them)
caused by their abnormal circadian regimen. The circadian
stage during which the meal is consumed affects eating
patterns and food selection (high-fat foods tend to be chosen
more at night) and also, intriguingly, diet-induced
thermogenesis (lower in the evening); both effects could
conceivably predispose to weight gain. Stress is also
implicated, perhaps via hypersecretion of cortisol. The
expression of the genes regulating food intake and body
weight may also be affected by desynchronisation of
circadian rhythms, and, excitingly, the discovery of
circadian oscillator genes in adipose tissue could have
potential therapeutic relevance.
Dietary fat, both total intake and composition, has for a
long time been associated with breast cancer, a relationship
subjected to scrutiny by Alexander et al. (9). Their
quantitative meta-analysis and review of epidemiological
cohort studies published to date, focusing on fat intake from
animal sources, actually does not support a positive
independent association in humans. However, they point
out that it must be borne in mind that the way in which food
intake data were collected (for example, FFQ v. 7 d food
diaries) could influence the accuracy of the results, and
future studies using improved methodologies could provide
a clearer picture. Also required is a plausible mechanism by
which dietary fat could lead to breast cancer – some areas of
investigation that could bear fruit include clarification of
the exact composition of the dietary fat, the timing of the
dietary exposure, and associations based on hormone
receptor status. Clearly, though, if any solid relationship is
ever to emerge, the quality of the dietary data upon which
it is based will be of paramount importance.
K. M. Younger
Editor-in-Chief
School of Biological Sciences
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